Article Text

Download PDFPDF
182 MyCare start: preliminary results of an early adopters study
  1. Fanny Mulder1,2,3,
  2. Stephen P Jenkinson1,3,4,
  3. Marc Dupuis1,2,
  4. Hélène Kirchhoffer3,
  5. Julia Krinelke3,
  6. Eva Von Wartburg3,
  7. Sarah Serhal5,6,
  8. Marie Schneider5,6,
  9. Karen Maes1,
  10. Alice Panchaud1,7
  1. 1Institute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland
  2. 2Graduated School of Health Sciences (GHS), University of Bern, Bern, Switzerland
  3. 3Swiss Pharmacists’ Association (pharmaSuisse), Liebefeld, Switzerland
  4. 4Centre for Primary Care and Public Health (Unisanté), University of Lausanne, Lausanne, Switzerland
  5. 5School of Pharmaceutical Sciences, University of Geneva, Switzerland
  6. 6Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, Switzerland
  7. 7Service of Pharmacy, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland

Abstract

Introduction One in four Swiss people live with a chronic disease1 and this proportion is increasing as the population ages. Chronic disease often goes hand in hand with long-term medication use. MyCare Start, developed in Switzerland by the Swiss Pharmacists’ Association, is a novel interprofessional service designed to support patients starting a new chronic treatment. It is based on the proof of concept established in the United Kingdom for the New Medicine Service.2 It consists of two short patient centered interventions given by a trained pharmacist about the new chronic medication. This preliminary assessment aims to describe the population recruited and its satisfaction level.

Methods More than 150 pharmacies agreed to participate (i.e. early adopters) in the first phase of an implementation study on myCare Start service in Switzerland. Any patients 18 years and more and capable of self-managing who have a prescription for a new chronic medication are asked in the early adopters’ pharmacies to participate and receive the myCare Start service. Patients reported outcomes are collected at three time points, one at baseline and two during the follow-up period (6 and 11 weeks). Each pharmacy is inviting physicians with whom they are collaborating and/or with a geographically close practice to set up an interprofessional community. Self-reported outcomes from pharmacists and physician are collected at three time points, one at baseline and two during the follow-up period (3 and 6 months). Self-reported outcomes will be compared at three study periods using a self-controlled case series design.3

Results Preliminary results will provide the numbers of patients and physicians recruited, the patient’s satisfaction level and the perception by Health Care Professionals on the quality of interprofessional collaboration.

Conclusion This study will inform the next steps of the myCare Start evaluation to allow comprehensive implementation at the national level.

References

  1. OBSAN. Cahier de l’Observatoire suisse de la santé. La santé en Suisse - Le point sur les maladies chroniques, Rapport national sur la santé 2015. 2015.

  2. https://www.nhs.uk/nhs-services/prescriptions-and-pharmacies/pharmacies/new-medicine-service-nms/

  3. Petersen I, Douglas I, Whitaker H. Self controlled case series methods: an alternative to standard epidemiological study designs. Bmj. 2016;354:i4515.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.